Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: JAMA Intern Med. 2014 Oct;174(10):1668–1673. doi: 10.1001/jamainternmed.2014.4005

Table 1.

Association Between Medical Cannabis Laws and State-Level Opioid Analgesic Overdose Mortality Rates in the United States, 1999–2010

Independent Variablea Percentage Difference in Age-Adjusted Opioid Analgesic Overdose Mortality in States With vs Without a Law
Primary Analysis
Secondary Analyses
Estimate (95% CI)b Estimate (95% CI)c Estimate (95% CI)d
Medical cannabis law −24.8 (−37.5 to −9.5)e −31.0 (−42.2 to −17.6)f −23.1 (−37.1 to −5.9)e

Prescription drug monitoring program 3.7 (−12.7 to 23.3) 3.5 (−13.4 to 23.7) 7.7 (−11.0 to 30.3)

Law requiring or allowing pharmacists to request patient identification 5.0 (−10.4 to 23.1) 4.1 (−11.4 to 22.5) 2.3 (−15.4 to 23.7)

Increased state oversight of pain management clinics −7.6 (−19.1 to 5.6) −11.7 (−20.7 to −1.7)e −3.9 (−21.7 to 18.0)

Annual state unemployment rateg 4.4 (−0.3 to 9.3) 5.2 (0.1 to 10.6)e 2.5 (−2.3 to 7.5)
a

All models adjusted for state and year (fixed effects).

b

R2 = 0.876.

c

All intentional (suicide) overdose deaths were excluded from the dependent variable; opioid analgesic overdose mortality is therefore deaths that are unintentional or of undetermined intent. All covariates were the same as in the primary analysis; R2 = 0.873.

d

Findings include all heroin overdose deaths, even if no opioid analgesic was involved. All covariates were the same as in the primary analysis. R2 = 0.842.

e

P ≤ .05.

f

P ≤ .001.

g

An association was calculated for a 1-percentage-point increase in the state unemployment rate.